Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ATOMOXETINE IMPURITY B CRS (10 MG)

ATOMOXETINE IMPURITY B CRS (10 MG)

83015-26-3

DISCOVER
ATOMOXETINE IMPURITY D CRS (5MG)

ATOMOXETINE IMPURITY D CRS (5MG)

NA

DISCOVER
METFORMIN IMPURITY A CRS (25 MG)

METFORMIN IMPURITY A CRS (25 MG)

NA

DISCOVER
FLUTAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

FLUTAMIDE FOR SYSTEM SUITABILITY CRS (10 MG)

NA

DISCOVER
IVY LEAF DRY EXTRACT HRS (70 MG)

IVY LEAF DRY EXTRACT HRS (70 MG)

NA

DISCOVER
DEXAMETHASONE FOR PEAK IDENTIFICATION CRS (20 MG)

DEXAMETHASONE FOR PEAK IDENTIFICATION CRS (20 MG)

50-02-2

DISCOVER
MEGESTROL ACETATE FOR IMPURITY K IDENTIFICATION CRS (0.01 MG

MEGESTROL ACETATE FOR IMPURITY K IDENTIFICATION CRS (0.01 MG

NA

DISCOVER
DIACEREIN CRS (150 MG)

DIACEREIN CRS (150 MG)

13739-02-1

DISCOVER
DIACEREIN IMPURITY B CRS (20 MG)

DIACEREIN IMPURITY B CRS (20 MG)

481-72-1

DISCOVER
DIACEREIN IMPURITY MIXTURE CRS (0.014 MG)

DIACEREIN IMPURITY MIXTURE CRS (0.014 MG)

13739-02-1

DISCOVER
DUTASTERIDE CRS (150 MG)

DUTASTERIDE CRS (150 MG)

164656-23-9

DISCOVER
WEDELOLACTONE CRS (15 MG)

WEDELOLACTONE CRS (15 MG)

524-12-9

DISCOVER